View Older Stories View More Recent Stories

May 9, 2017 07:53AM VolitionRx (VNRX) Presents Results from 8000 Patient Trial in Denmark Evaluating Performance of its Nu.Q Triage Test
May 9, 2017 07:30AM VolitionRx Limited Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate the Performance of its Nu.Q(TM) Triage Test
May 8, 2017 08:00AM VolitionRx Limited Schedules First Quarter 2017 Earnings Conference Call and Business Update
Apr 27, 2017 07:46AM Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe
Apr 21, 2017 08:26AM Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory
Apr 11, 2017 07:01AM Volitionrx Limited (VNRX) Appoints David Vanston as CFO
Apr 11, 2017 07:00AM VolitionRx Appoints David Vanston as Chief Financial Officer
Mar 28, 2017 04:03PM Volitionrx Limited (VNRX) Retains Strategic Consultant to Secure Non-Dilutive Funding Opportunities
Mar 28, 2017 04:01PM Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States
Mar 20, 2017 06:35AM Volitionrx Limited (VNRX) Forms Wholly-Owned U.S. Subsidiary
Mar 20, 2017 06:30AM VolitionRx Limited Announces the Formation of Volition America, Inc.
Mar 13, 2017 06:30AM VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time
Mar 10, 2017 06:30AM VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update
Mar 8, 2017 06:30AM VolitionRx Limited to Present at the 29th Annual ROTH Conference
Mar 6, 2017 05:00PM VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update
Mar 2, 2017 06:30AM A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark
Feb 24, 2017 06:30AM VolitionRx Limited's Triage Test Results Validated in Prospective Trial
Feb 23, 2017 09:00AM VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference
Feb 9, 2017 09:26AM VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017
Jan 5, 2017 06:30AM VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia
Jan 3, 2017 09:00AM VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe
Dec 28, 2016 06:30AM VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference
Dec 1, 2016 08:57AM VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference
Nov 11, 2016 06:30AM VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016
Nov 10, 2016 06:30AM VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update
Nov 4, 2016 06:30AM VolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update
Nov 3, 2016 06:37AM Volitionrx Limited (VNRX), Hvidovre Hospital Enter Cancer Blood Tests Clinical Study
Nov 3, 2016 06:30AM VolitionRx Limited and Hvidovre Hospital Begin Large Prospective Clinical Study
Oct 26, 2016 06:30AM VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition
Oct 21, 2016 11:34AM VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter
Oct 17, 2016 06:30AM Triage Blood Test Data Presented to Leading International Experts at the World Endoscopy Organization's Colorectal Cancer Screening Committee
Oct 11, 2016 08:33AM Volitionrx Limited (VNRX) Announces Presentation of Positive Blood Test for Colorectal Cancer Data
Oct 11, 2016 08:30AM Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25%
Oct 5, 2016 12:14PM VolitionRx Limited Announces Closing of Public Offering of Common Stock
Sep 30, 2016 08:47AM Volitionrx Limited (VNRX) Prices 2.25M Common Stock Offering at $5/Share
Sep 30, 2016 08:45AM VolitionRx Limited Announces Pricing of Public Offering of Common Stock
Sep 29, 2016 04:06PM Volitionrx Limited (VNRX) to Offer Common Stock
Sep 29, 2016 04:02PM VolitionRx Limited Announces Proposed Public Offering of Common Stock
Sep 7, 2016 06:30AM VolitionRx to Attend Several Conferences in September
Sep 7, 2016 06:30AM VolitionRx to Attend Several Conferences in September
Sep 6, 2016 06:30AM Volition's Nu.Q Triage Colorectal Cancer Screening Test Expected to Reduce Colonoscopy Referral by 25 Percent
Sep 6, 2016 06:30AM Volition's Nu.Q Triage Colorectal Cancer Screening Test Expected to Reduce Colonoscopy Referral by 25 Percent
Sep 1, 2016 06:30AM VolitionRx Schedules Product Launch Update Conference Call for Tuesday, September 6, 2016 at 8:30 am ET
Sep 1, 2016 06:30AM VolitionRx Schedules Product Launch Update Conference Call for Tuesday, September 6, 2016 at 8:30 am ET
Aug 11, 2016 06:30AM VolitionRx Announces Second Quarter 2016 Financial Results and Business Update
Aug 8, 2016 06:30AM VolitionRx Schedules Second Quarter 2016 Earnings Conference Call and Business Update for Thursday, August 11, 2016 at 8:30am ET
Aug 2, 2016 07:00AM VolitionRx Engages Edison Advisors as Investor Relations Counsel
Jul 27, 2016 07:00AM VolitionRx Granted Fourth U.S. Patent
Jun 24, 2016 07:00AM VolitionRx Appoints Dr. Edward Futcher to Board of Directors
Jun 14, 2016 07:15AM Volitionrx Limited (VNRX) Announces Publication of Positive NuQ Blood Test Assessment Data
View More Recent Stories View Older Stories